Video summary

CNSP Lecture - Creams & Ointments (semi-solids)

Main summary

Key takeaways

Educational

Main ideas / lessons conveyed

  • Semi-solid dosage forms include creams and ointments, both intended for external use on skin or mucous membranes.
  • Distinguishing “cream vs ointment” has historically been confusing because older definitions overlap.
  • Modern practice relies on revised definitions and base composition, since the base strongly influences:
    • Physical feel
    • Water handling
    • Drug delivery
    • Stability
    • Patient acceptability

Definitions and distinguishing creams vs ointments

Traditional definitions (overlap → confusion)

  • Ointment (traditional): semi-solid preparation for external application to skin or mucous membranes.
  • Cream (traditional): semi-solid dosage form with one or more drugs dissolved or dispersed in a suitable base.

Because these overlap, the same term could be used broadly under older usage.

Modern / revised definitions (manufacturer-oriented)

  • Ointment (modern): a viscous oleaginous or polymeric semi-solid dosage form.

    • Base characteristics commonly include:
      • Hydrocarbon/oleaginous → greasy, thick, stiff
      • Not water-washable
    • Examples: white petrolatum (e.g., Vaseline/Aquaphor-type hydrocarbon components) and similar hydrocarbon bases.
  • Cream (modern): drug incorporated into a viscous semi-solid emulsion.

    • “Emulsion” matters because creams are typically:
      • Oil-in-water → white, soft, water washable
      • Or water-in-oil
      • Or water-soluble-type bases, depending on formulation
    • Multiple emulsion systems exist → multiple “cream-like” products.

Why compound topical semi-solids (purpose of compounding)

  • The main reason to compound is to use the base as a vehicle to deliver the active drug to the skin.
  • The active drug may be intended for:
    • Local effect (e.g., topical anti-infective for skin infection)
    • Systemic effect via absorption (e.g., estrogen-containing cream for menopause symptoms)
  • Regardless of drug intent, base selection is crucial because the base contributes key properties.

Base properties to consider (what the base must do)

Three distinctive properties (core functions)

  1. Molding / emollient action & relief

    • Can soften skin and help with local irritation.
  2. Protectant action

    • Protects injured/exposed skin from harmful or discomforting stimuli.
  3. Occlusive action

    • Promotes water retention by forming a hydrophobic barrier.
    • Reduces water evaporation/removal from skin.

Additional practical requirements for bases

  • Chemical and physical stability under normal storage/use
  • Nonreactive and compatible with many drugs and formulation agents
  • Free from objectionable odor
  • Non-toxic and non-irritating / non-sensitizing, especially for sensitive skin
  • Aesthetics & usability
    • Generally non-greasy and easy to apply
  • Proper residence time
    • Must remain on skin until removal is desired
    • Preferably removable with water when applicable

How to choose whether the formulation should be a cream or an ointment (base choice logic)

The choice depends on three main factors:

  1. Nature of the drug

    • Must be bioavailable (readily absorbed from the base)
    • Consider stability/compatibility:
      • Water-containing bases may promote drug hydrolysis/inactivation
      • Drug may change pH, reducing emulsifier effectiveness
  2. Desired base properties

    • Choose base to provide:
      • Emollience/softening (molding)
      • Protection
      • Occlusion / water retention
  3. Area of application

    • May be applied to skin, eyes, rectal, or vaginal sites
    • Must be compatible and non-irritating for that location

Safety / authority instruction

  • If a prescription specifies a particular base and it’s not compatible with the prescribed drug:
    • Consult the prescriber
    • Pharmacists should not change the base without prescriber approval

The five classes of semi-solid bases (pharmacist must recognize)

The lecture frames five base categories, with distinct physical behavior:

  1. Hydrocarbon / oleaginous bases

    • Examples: petrolatum, white petrolatum
    • Characteristics:
      • Greasy, stiff; yellowish or white (decolorized)
      • Cannot absorb water
      • Not water-washable; limited alcohol uptake
  2. Anhydrous absorption bases

    • Example: Aquaphor
    • Characteristics:
      • Similar look to hydrocarbon bases
      • Contains emulsifier → can absorb/hold some water despite being “anhydrous”
  3. Water-and-oil emulsion absorption bases

    • Example: Eucerin
    • Characteristics:
      • Often looks “cream-like,” but behaves as an emulsion system
      • Contains water → can absorb additional water (to a limit)
  4. Water-removable bases (oil-in-water emulsion bases)

    • Examples: vanishing creams / Velva-type product (as referenced in subtitles)
    • Characteristics:
      • Water is the external phase
      • Soft, light, water washable
      • Can accept water/water-miscible liquids in the external phase
      • Not very occlusive compared with earlier classes
  5. Water-soluble bases

    • Examples: poly bases / polyethylene glycol ointment-type bases
    • Characteristics:
      • Soluble in water and alcohol
      • Accept limited water/alcohol without losing viscosity
      • Non-greasy, easy to wash off
      • Limited emollient effect; may be irritating to denuded skin/mucosa
      • Some PEG types can have drug compatibility issues

Preparation & compounding: goals and procedures (instructional bullets)

Compounding goal #1: produce a homogeneous (well-blended) product

  • Core challenge: solids may be present as powders → must be dispersed evenly.
  • Typical tools:

    • Ointment pad (paper-like surface)
      • Pros: no cleanup
      • Cons: may absorb aqueous liquids; can tear with sticky bases
    • Ointment slab (ceramic/glass)
      • Pros: handles liquids well; reusable
      • Cons: must be cleaned thoroughly afterward
  • Tools for mixing:

    • Spatulas and rubber policemen
    • Spatula selection:
      • Metal spatulas for lifting/dispensing powders and product
      • Rubber policemen for scraping in mortar situations
  • Special processing:

    • Ointment mill (rollers)
      • Reduces particle size (down to ~20 microns mentioned)
      • Improves homogeneity; minimizes grittiness
      • Reduces personnel exposure
    • Electric mixers may be used for automated emulsions/creams

Compounding goal #2: produce a product smooth, non-gritty

  • Ensure solids are at the finest particle size possible.
  • Strategies:
    • Start with finer commercially available forms
    • If a specific form is required by prescriber:
      • Use that form unless you contact prescriber to change
    • Use mortar and pestle for most powders
    • Use levigation / triturating to create smooth dispersion

Levigation (workflow concept)

  • Purpose: wet solids and reduce particle size using shear with a lubricating agent.
  • Conceptual method:
    1. Place powder on ointment pad/slab
    2. Make a small divot
    3. Add small portions of levitating agent (e.g., glycerin/mineral oil)
    4. Triturate/levigate until powder is completely wetted
    5. Stop when no dry powder remains (thick paste formed)

Selecting an auxiliary levitating agent (minimized-change rule)

  • If formulation already includes an appropriate liquid ingredient → use it.
  • If not, choose based on compatibility with the base external phase:
    • Hydrocarbon / anhydrous absorption / water-in-oil emulsion bases → mineral oil
    • Oil-and-water emulsion / water-soluble bases → glycerin

General compatibility rule

  • Levigation agent should be chemically similar to the base’s external phase.

Choosing the quantity of levitating agent

  • Use the minimum amount needed to:
    • Wet solids
    • Lubricate
    • Liquefy them enough for smooth mixing
  • Constraints:
    • Too much can alter consistency (e.g., cream becomes too “lotion-like”)
    • In emulsions, too much added liquid can crack or destabilize the emulsion

Documentation & calculations (step-by-step)

  1. Account for excess formulation

    • Prepare 10% excess (lecture practice) to allow for losses.
    • Example: target 45 g → prepare 49.5 g
  2. Calculate active ingredient quantity

    • Use prescribed concentration (e.g., 10% w/w → active = 10% of final computed weight)
  3. Determine levitating agent volume used

    • Only determined after physically levigating powder (measure volume).
    • Measure with syringe or graduated device.
  4. Convert levitating agent volume to weight

    • Use specific gravity as density:
      • Mineral oil SG ≈ 0.88
      • Glycerin SG ≈ 1.26
  5. Compute remaining base weight

    • Total prepared weight = base + active + levitating agent weight
    • Base weight = (total prepared) − (active weight) − (levitating agent weight)

Lecture worked examples (concept summary)

  • Example 1: Zinc oxide 10% in an anhydrous absorption base

    • Mineral oil used for levigation (base-compatible)
    • Mineral oil volume measured (e.g., 2 mL)
    • Convert volume to weight using SG
    • Compute remaining base mass to reach total weight
  • Example 2: Zinc oxide 10% in a water-removable / oil-and-water emulsion base

    • Glycerin used for levigation (base-compatible)
    • Glycerin volume measured (e.g., 1.5 mL)
    • Convert volume to weight using glycerin SG
    • Compute remaining base mass to reach total weight

If the active ingredient is already a liquid

  • Levigation is not required for liquids like LCD (as referenced).
  • Key precautions:
    • Base must be able to absorb the liquid
      • Failure example: liquid added to pure hydrocarbon vaseline → puddles on top
      • Fix: switch to an absorption base (e.g., aquaphor-type)
    • Use careful technique:
      • Liquids can splash (low surface tension)
      • Consider a hard surface slab if liquid amount is significant
    • Absorption takes time:
      • Add liquid gradually and triturate gently, using a depression/divot method

Preparation guidelines after compounding

Guideline 1: beyond-use dating (BUD) — stability-based

  • Use stability references when available.
  • If not available, use conservative estimates and monitor for instability signs:

    • Discoloration
    • Consistency changes
    • Odor changes
  • Physical instability issues:

    • Bleeding (separation of liquid ingredients via phase separation)
    • Evaporation of water → drying/shrinking/cracking
    • Granule formation & grittiness as base shrinks
  • Chemical instability considerations:

    • Water-containing levigating agents (e.g., glycerin/water) can increase hydrolysis
    • pH-sensitive emulsifiers → incompatible with acids (example includes vanishing creams and salicylic acid/phenolics)
  • Microbial instability:

    • USP emphasizes that emulsions require antimicrobials
    • Some commercial bases include preservatives, which may reduce the need for added preservatives
  • Default rule when no stability info/concerns:

    • USP 795-based guidance mentioned: for water-containing topical dermal/mucosal products, BUD not later than 30 days

Guideline 2: packaging

  • Choose container type based on route/physical characteristics:
    • Jars for thick/stiff ointments
    • Tubes/pumps/syringes for better contamination control
  • Packaging should be tight:
    • Minimize air exposure and microbial contamination
  • Jar-filling technique:
    • Tap to remove air pockets
    • Smooth/dress top for finish (“icing cake” analogy)
    • Don’t overfill; avoid product sticking to lid threads

Guideline 3: quality control & labeling

Quality control / compounding record must include

  • Final weight
  • Visual appearance, color, odor (if any)
  • Viscosity/texture description

Prescription label must include

  • Active ingredient names and strengths (e.g., “Zinc oxide 10%, Calamine 5%”)
  • Commercial base name (because it affects product properties)
  • Route of application (e.g., topical; rectal/vaginal if applicable)
  • Dosage form (cream, ointment, paste)

Not on label (but documented in compounding record)

  • Auxiliary ingredients such as levitating agents (typically not listed on prescription label)
  • Patient warning labeling as relevant:
    • Keep away from/restrict access by children

Speakers / sources featured

  • Dr. Speidel (TA/supervisor)
  • Dr. Lanky (TA/supervisor)
  • USP (U.S. Pharmacopeia) guidance cited:
    • USP Chapter 795
    • USP Chapter 1795 (as referenced for BUD default)

Rate this summary

Your feedback will help improve summaries.

Improve this summary

Reprocess with a stronger model when the summary feels incomplete or inaccurate.

Pro

Translate summary in another language

Pro

Ask questions to this video

Chat for follow-up questions, clarifications, and source-backed answers.

Coming soon

Share this summary

Original video